Image For Activity Cover
Clinical EP Laboratory Techniques and Interpretations
Description

This three-part course is designed to review arrhythmia mechanisms and mapping/ablation strategies in patients with SVT, atrial fibrillation/flutter, and ventricular arrhythmias for the EP professional.These sessions were presented as part of the Allied Professionals Forum at HRS Scientific Sessions 2019.  The Allied Professional Forum promotes quality education and inspire attendees to expand scientific discovery to apply it to their daily practice.

For information on registering for the 2020 Allied Professionals Forum and other sessions at #HRS2020, please click here.  

Presentations

Arrhythmia Mechanisms and EGM Interpretation

Understanding Our History: The Rapid Evolution of Electrophysiology from Mechanistic Investigation to Major Clinical Therapies
Melvin M. Scheinman, MD, FHRS, Univ of California-San Francisco, Cardiac EP, San Francisco, CA

Burn It In Your Brain!" - Key ECG Patterns that Help Discern Arrhythmia Mechanisms and Anatomical Relationships"
Scott J. Cox, MS, PAC, CEPS, CCDS, Main Line Health System, Newtown, PA

The Diagnostic EP Study - Initial EGM Interpretation and Conduction System Characterization
Jonathan W. Waks, MD, Beth Israel Deaconess Medical Center, Chestnut Hill, MA

Induction of Sustained Tachycardia During EPS: Step-wise Approach for Identifying the Differential Diagnoses
Samir F. Saba, MD, FHRS, Univ of Pittsburgh Medical Cen, Pittsburgh, PA

Catheter Ab
lation of Atrial Arrhythmias

AF Ablation in 2019 and Beyond: Review of Current Strategies and Promising Future Directions

Kirstan Clay-Weinfeld, BSN, MSN, ACNP, CCRN, Penn Medicine - Pennsylvania H, Wilmington, DE

Collateral Damage During AF Ablation: How Do we Minimize Risk and Maximize Therapeutic Benefit?
Erin E. Flatley, BSN, MSN, NP, University of California San Francisco, San Francisco, CA 

Reversing AF Disease by Lifestyle Management: Current Role and Potential Implications for Timing and Recommendation of AF Ablation
Melissa E. Middeldorp, Centre for Heart Rhythm Disorders, Norwood, Australia 

Catheter Ablation of Ventricular Arrhythmias

Evolution of VT Ablation - What Have We Learned and Where Are We Going?
Cory M. Tschabrunn, PhD, CEPS, University of Pennsylvania, Philadelphia, PA

VT Ablation Pre-procedure Planning: Role of Imaging, Hemodynamic Support, and Special Considerations
Erica S. Zado, PAC, FHRS, Hospital of the Univ of Pennsylvania, EP, Philadelphia, PA 

Approaching Current Challenges in VT Mapping and Ablation: Lesion Enhancement Techniques
Jonathan W. Waks, MD, Beth Israel Deaconess Medical Center, Chestnut Hill, MA

Induction of Sustained Tachycardia During EPS: Step-wise Approach for Identifying the Differential Diagnoses
Wendy S. Tzou, MD, FHRS, University of Colorado Denver, Aurora, CO




 

Learning Objectives

To review arrhythmia mechanisms and cardiac anatomy for the EP professional
To review SVT arrhythmia differentiation in the EP lab
To review fundamentals of AF and VT ablation procedures

Target Audiences
Technologist
Nurse
Physician's Assistant
CME Information
ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMEN
T

The Heart Rhythm Society designates this enduring activity for a maximum of 4.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

A CME Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™ or have identified credit awarded by ACCME accredited providers as being “substantially equivalent” to their own. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:

· American Academy of Family Practice (AAFP) for elective credit

· American Academy of Nurse Practitioners Certification Board (AANPCB)

· American Academy of Physician Assistants (AAPA)

· American Nurses Credentialing Center (ANCC)

· American Osteopathic Association (AOA) for Category 2 credit

· Committee on Accreditation of Continuing Medical Education  (Canada) 

· European Board of Accreditation in Cardiology (EBAC)

· European CME Credits (ECMEC)

· German Chambers of Physicians

· Oman Medical Specialty Board 

· Qatar Council for Health Practitioners 

· Royal College of Physicians and Surgeons of Canada 

DISCLOSURE POLICY
The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant financial relationships (for self and for spouse/partner) with an ACCME-defined commercial interest within the 12 months prior to the disclosure.

VALIDATION

Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

  • Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.
  • Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.
  • Scientific Validity - that scientific studies cited in the activity conform to standards accepted by the scientific community.
  • Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
  • Omission and Commission - are there any studies, data, or best evidence that is missing?
MOC Information

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 4.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Disclosures

C.M. Tschabrunn: Research (Contracted Grants for PIs and Named Investigators only) - Biosense Webster, Inc.; Attune Medical.
A.J. Cambridge: Nothing relevant to disclose.
M.M. Scheinman: Nothing relevant to disclose.
E.E. Flatley: Nothing relevant to disclose.
K. Clay-Weinfeld: Nothing relevant to disclose.
M.E. Middeldorp: Nothing relevant to disclose.
E.S. Zado: Nothing relevant to disclose.
W.S. Tzou: Honoraria/Speaking/Consulting Fee - Biosense Webster, Inc.; Abbott Laboratories; Boston Scientific; Medtronic, Inc.; Biotronik.
M.E. Middeldorp: Nothing relevant to disclose.
S.J. Cox:  Honoraria/Speaking/Consulting Fee - ScottCare Inc,; Abbott Laboratories.
J.W. Waks: Payment for Clinical Endpoint Committee - Baim Clinical Research Institute.
S.F. Saba:  Honoraria/Speaking/Consulting Fee - Boston Scientific. Research (Contracted Grants for PIs and Named Investigators only) - Boston Scientific; Medtronic, Inc 


Summary
Availability: On-Demand
Available Jan 03, 2020 to Jan 03, 2022
Cost: Member: $100.00
Non-Member: $200.00
Credit Offered: 4 ABIM-MOC Points
4 CME Credits
4 COP Credits
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Powered By